neurological

R&D

Epilepsy affects women differently than men, owing to the complexity of brain health and the historical lack of investment in women’s health.

Views & Analysis

Getting a diagnosis is often the biggest challenge facing a rare disease patient in the UK.

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.